Stockreport

Trevi Therapeutics Announces Proposed Public Offering of Common Stock

Trevi Therapeutics, Inc.  (TRVI) 
PDF NEW HAVEN, Conn., April 16, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational [Read more]